Adenosine A(2A) receptor blockade reverts hippocampal stress-induced deficits and restores corticosterone circadian oscillation. |
|
Adenosine A2A Receptors Modulate α-Synuclein Aggregation and Toxicity. |
|
Adenosine A3 receptors are located in neurons of the rat hippocampus |
|
Adenosine and related drugs in brain diseases: present and future in clinical trials |
|
The Amyloid Precursor Protein C-Terminal Domain Alters CA1 Neuron Firing, Modifying Hippocampus Oscillations and Impairing Spatial Memory Encoding |
|
Beneficial Effect of a Selective Adenosine A Receptor Antagonist in the APPswe/PS1dE9 Mouse Model of Alzheimer's Disease |
|
Binding of the prototypical adenosine A(2A) receptor agonist CGS 21680 to the cerebral cortex of adenosine A(1) and A(2A) receptor knockout mice. |
|
The caffeine-binding adenosine A2A receptor induces age-like HPA-axis dysfunction by targeting glucocorticoid receptor function. |
|
Chronic and acute adenosine A2A receptor blockade prevents long-term episodic memory disruption caused by acute cannabinoid CB1 receptor activation. |
|
Design and synthesis of fused tetrahydroisoquinoline-iminoimidazolines |
|
Design, synthesis and evaluation of 2-aryl benzoxazoles as promising hit for the A2A receptor. |
|
Effects of carbamazepine and novel 10,11-dihydro-5H-dibenz[b,f]azepine-5-carboxamide derivatives on synaptic transmission in rat hippocampal slices |
|
Enhancement of LTP in aged rats is dependent on endogenous BDNF. |
|
Erratum: A2A adenosine receptor deletion is protective in a mouse model of Tauopathy |
|
Escitalopram improves memory deficits induced by maternal separation in the rat. |
|
Exacerbation of C1q dysregulation, synaptic loss and memory deficits in tau pathology linked to neuronal adenosine A2A receptor |
|
Extracellular alpha-synuclein oligomers modulate synaptic transmission and impair LTP via NMDA-receptor activation. |
|
From epidemiology to pathophysiology: what about caffeine in Alzheimer's disease? |
|
Glycation potentiates α-synuclein-associated neurodegeneration in synucleinopathies. |
|
Impact of in vivo chronic blockade of adenosine A2A receptors on the BDNF-mediated facilitation of LTP. |
|
Increase in the number, G protein coupling, and efficiency of facilitatory adenosine A2A receptors in the limbic cortex, but not striatum, of aged rats. |
|
Inhibition of NMDA Receptors Prevents the Loss of BDNF Function Induced by Amyloid β. |
|
Interacção entre os receptores de adenosina no hipocampo de rato |
|
Maternal deprivation affects the neuromuscular protein profile of the rat colon in response to an acute stressor later in life |
|
Maternal separation impairs long term-potentiation in CA1-CA3 synapses and hippocampal-dependent memory in old rats. |
|
Meningeal γδ T cell-derived IL-17 controls synaptic plasticity and short-term memory |
|
Modification of adenosine modulation of acetylcholine release in the hippocampus of aged rats. |
|
Modulating Alzheimer's disease through caffeine: a putative link to epigenetics. |
|
Multicompartment Microreactors Prevent Excitotoxic Dysfunctions In Rat Primary Cortical Neurons |
|
Mutant A53T α-Synuclein Improves Rotarod Performance Before Motor Deficits and Affects Metabolic Pathways. |
|
Neuroprotection afforded by adenosine A2A receptor blockade is modulated by corticotrophin-releasing factor (CRF) in glutamate injured cortical neurons. |
|
Overexpression of Adenosine A2A Receptors in Rats: Effects on Depression, Locomotion, and Anxiety |
|
Prolactin-induced neuroprotection against glutamate excitotoxicity is mediated by the reduction of [Ca2+]i overload and NF-κB activation |
|
Proteomics of the rat gut: analysis of the myenteric plexus-longitudinal muscle preparation. |
|
Purines in portugal. |
|
Sensing α-Synuclein From the Outside via the Prion Protein: Implications for Neurodegeneration |
|
Tapentadol Prevents Motor Impairments in a Mouse Model of Dyskinesia |
|
ZM 241385, an adenosine A2A receptor antagonist, inhibits hippocampal A1 receptor responses |
|
α-synuclein interacts with PrPC to induce cognitive impairment through mGluR5 and NMDAR2B. |
|